(March 22, 2017, 9:15 AM EDT) -- NEW YORK — Novartis Pharmaceuticals Corp. (NPC) on March 14 asked a federal court to conduct a pre-motion conference, saying it wants partial summary judgment preventing the United States from using “markers” to show the drug company conducted sham medical education events and paid unlawful kickbacks to health care providers (United States of America, ex rel. Oswald Bilotta v. Novartis Pharmaceuticals Corp., No. 11-71, S.D. N.Y.)....